Satiety fills up on $25.3M for obesity treatments

Satiety, maker of a minimally-invasive medical device that reduces obesity, has raised $25.3 million of an anticipated $33 million round of equity and rights, according to a filing with the SEC. The Palo Alto, Calif. company was previously backed by HLM Venture Partners, Morgenthaler Ventures, Pinnacle Ventures, Skyline Ventures, Thomas Fogarty, Three Arch Partners and Venrock. It has raised four rounds of funding to date, not including a $7.5 million bridge loan from its investors brought in early this year.